We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
31 hedge funds and large institutions have $228M invested in Corvus Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$75.4M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$45.3M |
| 3 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$38.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.11M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Tudor Investment Corp
Stamford,
Connecticut
| $145K | +$143K | +10,000 | New |
|
|
BIM
27
BlackRock Investment Management
Wilmington,
Delaware
| $74K | +$73.2K | +5,100 | New |
|
|
BIT
28
BlackRock Institutional Trust
San Francisco,
California
| $44K | +$43.4K | +3,024 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $44K | +$43.7K | +3,044 | New |
|
30
Citigroup
New York
| $7K | +$7.17K | +500 | New |
|
31
Morgan Stanley
New York
| $3K | +$3.14K | +219 | New |
|
|
CCA
32
Catalyst Capital Advisors
Huntington,
New York
| $2K | +$2.37K | +165 | New |
|